Novel inhibitors of protein arginine methyltransferase 5 (PRMT5) for the treatment of solid tumors

被引：0

作者：

Chikkanna, Dinesh ^{[1
]}

Panigrahi, Sunil Kumar ^{[1
]}

Rajagopalan, Sujatha ^{[1
]}

Sammeta, Srinivasa Raju ^{[1
]}

Lakshminarasimhan, Anirudha ^{[1
]}

Mohan, R. ^{[1
]}

Narasihmarao, K. ^{[1
]}

Chawla, Darshan ^{[1
]}

Bhat, Harsha ^{[1
]}

Kasturi, Venkateswarlu ^{[1
]}

Samiulla, D. S. ^{[1
]}

Prasanna, Angelene ^{[1
]}

Aithal, Kiran ^{[1
]}

Chand, Priyabrata Chand ^{[1
]}

Kumar, Naveen ^{[1
]}

Marri, Sai Sudheer ^{[1
]}

Ganipisetty, Srinivasa Rao ^{[1
]}

Rao, Kasieswara N. ^{[1
]}

Mutyala, Raju ^{[1
]}

Neerukattu, Nageswara Rao ^{[1
]}

Nithesh, K. ^{[1
]}

Amin, Ramya ^{[1
]}

Gorade, Priyanka Machhindra ^{[1
]}

Antony, Thomas ^{[1
]}

Daginakatte, Girish ^{[1
]}

Chelur, Shekar ^{[1
]}

Pandit, Chetan ^{[1
]}

Samajdar, Susanta ^{[1
]}

Ramachandra, Murali ^{[1
]}

机构：

[1] Aurigene Discovery Technol Ltd, Bangalore, Karnataka, India

来源：

MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期

关键词：

D O I：

10.1158/1535-7163.TARG-17-A174

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A174

引用

页数：2

共 50 条

[1] Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors
Lin, Hong
Luengo, Juan, I
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1264 - 1269
[2] Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
Palte, Rachel L.
Schneider, Sebastian E.
Altman, Michael D.
Hayes, Robert P.
Kawamura, Shuhei
Lacey, Brian M.
Mansueto, My Sam
Reutershan, Michael
Siliphaivanh, Phieng
Sondey, Christopher
Xu, Haiyan
Xu, Zangwei
Ye, Yingchun
Machacek, Michelle R.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (09): : 1688 - 1693
[3] Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
Lin, Hong
Wang, Min
Zhang, Yang W.
Tong, Shuilong
Leal, Raul A.
Shetty, Rupa
Vaddi, Kris
Luengo, Juan I.
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1033 - 1038
[4] Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
Feustel, Kavanya
Falchook, Gerald S.
JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (03) : 58 - 67
[5] Protein arginine methyltransferase 5 (PRMT5) is a novel negative regulator of keratinocyte differentiation
Kanade, S. R.
Eckert, R. L.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S60 - S60
[6] Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
Rasheed, Shayaan
Bouley, Renee A.
Yoder, Ryan J.
Petreaca, Ruben C.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
[7] Protein arginine methyltransferase 5 (PRMT5) is a novel coactivator of constitutive androstane receptor (CAR)
Kanno, Yuichiro
Inajima, Jun
Kato, Sayaka
Matsumoto, Maika
Tokumoto, Chikako
Kure, Yuki
Inouye, Yoshio
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (01) : 143 - 147
[8] Novel, small molecule protein arginine methyl transferase 5 (PRMT5) inhibitors for treatment of glioblastoma
Sivanandhan, D.
Garapaty, S.
Seerapu, G. P.
Das, R.
Kapoor, N.
Kar, R.
Singh, A. K.
Vadivelu, S.
Gangaiah, R.
Mohd, Z.
Tamizharasan, N.
Swamy, I.
Subramaniam, K.
Tibhe, J.
Vaidyalingam, K.
Birudukota, S.
Thiagaraj, D.
Burri, R. R.
Rajagopal, S.
Rajagopal, S.
EUROPEAN JOURNAL OF CANCER, 2018, 103 : E120 - E120
[9] A role for protein arginine methyltransferase 5 (PRMT5) in the mechanism of novel anticancer agent, AS1411.
Teng, Yun
Bates, Paula J.
CANCER RESEARCH, 2006, 66 (08)
[10] Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer
Guo, Chaohua
Wu, Lintao
Zheng, Xumei
Zhao, Lin
Hou, Xiaojia
Wang, Zhijun
Han, Chun
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (21) : 2048 - 2074

← 1 2 3 4 5 →